Shares of Sage Therapeutics Inc. fell more than 18% premarket on Wednesday after a failed trial dealt a blow to the company’s collaboration with Biogen Inc.
Source link
Trump’s pick to lead the DEA withdraws from consideration
Hillsborough County Sheriff Chad Chronister shares support for Florida Gov Ron DeSantis' announcement of the suspension of Hillsborough County State...